Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1958 4
1972 4
1973 3
1974 1
1975 3
1976 3
1977 5
1978 2
1979 2
1980 2
1981 4
1982 5
1983 5
1984 3
1985 8
1986 9
1987 7
1988 11
1989 11
1990 6
1991 8
1992 13
1993 13
1994 15
1995 12
1996 7
1997 12
1998 13
1999 11
2000 7
2001 17
2002 4
2003 6
2004 15
2005 13
2006 11
2007 6
2008 18
2009 6
2010 7
2011 2
2012 6
2013 3
2014 3
2015 4
2016 3
2017 1
2018 3
2019 1
2020 3
2021 2
2022 1
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Results by year

Filters applied: . Clear all
Page 1
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.
Dietz J, Müllhaupt B, Buggisch P, Graf C, Peiffer KH, Matschenz K, Schattenberg JM, Antoni C, Mauss S, Niederau C, Discher T, Trauth J, Dultz G, Schulze Zur Wiesch J, Piecha F, Klinker H, Müller T, Berg T, Neumann-Haefelin C, Berg CP, Zeuzem S, Sarrazin C; German HCV Resistance Study Group; University Hospitals; Academic Hospitals; Local study sites (private practices), Germany. Dietz J, et al. J Hepatol. 2023 Jan;78(1):57-66. doi: 10.1016/j.jhep.2022.08.016. Epub 2022 Aug 27. J Hepatol. 2023. PMID: 36031158
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.
Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P, Peiffer KH, Vermehren J, Dultz G, Geier A, Reiter FP, Bruns T, Schattenberg JM, Durmashkina E, Gustot T, Moreno C, Trauth J, Discher T, Fischer J, Berg T, Kremer AE, Müllhaupt B, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. JHEP Rep. 2024 Mar 25;6(7):101072. doi: 10.1016/j.jhepr.2024.101072. eCollection 2024 Jul. JHEP Rep. 2024. PMID: 39006503 Free PMC article.
[Options in HIV therapy: present and future].
Röling J, Draenert R, Goebel FD. Röling J, et al. Among authors: goebel fd. Internist (Berl). 2005 Aug;46(8):892-4, 896-8. doi: 10.1007/s00108-005-1453-2. Internist (Berl). 2005. PMID: 15968521 Review. German.
339 results